Introduction to Parkinson’s Disease

Parkinson’s disease (PD) is a progressive neurodegenerative disorder primarily affecting the motor system due to dopaminergic neuron loss in the substantia nigra. First described by James Parkinson in 1817, PD manifests predominantly in individuals aged 50 and above, though the average age of onset in India is 58 years, earlier than the global average of 60-65 years (NIMHANS, 2023). As of 2023, India has an estimated 1 million PD patients, with a prevalence rate of 77 per 100,000 population (ICMR National Neurological Registry; Neurology India, 2022). The disease’s significance lies in its dual burden of motor and non-motor symptoms, impacting quality of life and healthcare systems amid rising prevalence.

Clinical Features: Motor and Non-Motor Symptoms

Parkinson’s disease is characterized by a combination of motor and non-motor symptoms. Motor symptoms arise from dopaminergic deficits affecting basal ganglia circuits, while non-motor symptoms involve widespread neurochemical changes.

• Motor symptoms: Resting tremor (4-6 Hz, typically unilateral), bradykinesia (slowness of movement), rigidity (cogwheel or lead-pipe), and postural instability. Tremor in PD differs from essential tremor by its resting nature and asymmetry.
• Non-motor symptoms: Depression affects 40-50% of PD patients (The Hindu, 2024), alongside cognitive impairment, autonomic dysfunction (constipation, orthostatic hypotension), sleep disturbances, and anosmia.
• Mortality and morbidity: PD patients have a 1.5 times higher mortality risk over 10 years compared to the general population (WHO Global Burden of Disease Report, 2023).

Legal and Policy Framework Governing Parkinson’s Disease in India

India’s legal framework recognizes neurological disabilities under the Rights of Persons with Disabilities Act, 2016. Section 2(h) explicitly includes neurological conditions, while Section 32 mandates government action to ensure healthcare access. The Mental Healthcare Act, 2017 complements this by securing mental health service access (Sections 18 and 21), critical given PD’s neuropsychiatric manifestations.

The National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) under the Ministry of Health and Family Welfare includes neurological disorders, but lacks dedicated PD protocols. Article 21 of the Constitution underpins the right to health and life, reinforcing state responsibility.

Economic Burden and Healthcare Infrastructure

India’s healthcare expenditure on neurological disorders exceeds INR 1,000 crore annually (Indian Journal of Public Health, 2023), yet less than 1% of the National Health Mission budget targets neurological diseases specifically. Out-of-pocket expenditure constitutes approximately 62% of total health spending for chronic neurological illnesses (NHA 2020), imposing significant financial strain on patients.

• The global Parkinson’s therapeutics market was valued at USD 4.5 billion in 2023, with a projected CAGR of 7.2% till 2030 (Grand View Research, 2024), indicating rising demand for treatment.
• Increasing PD prevalence could reduce India’s workforce productivity by up to 0.3% annually by 2030 (WHO Global Burden of Disease Report, 2023).
• Only 30% of PD patients in rural India access specialized neurological care, highlighting urban-rural disparities (Indian Journal of Public Health, 2023).

Key Institutions and Their Roles

• Indian Council of Medical Research (ICMR): Conducts epidemiological research and maintains the National Neurological Registry.
• National Institute of Mental Health and Neurosciences (NIMHANS): Premier neurological treatment and research institute.
• Ministry of Health and Family Welfare (MoHFW): Formulates policies including NPCDCS.
• Parkinson’s Disease Society of India (PDSI): Provides patient support and awareness campaigns.
• World Health Organization (WHO): Offers global guidelines and data on neurological disorders.

Comparative Analysis: India vs Japan

Critical Gaps in India’s Parkinson’s Disease Management

• Absence of a dedicated national PD registry impedes accurate prevalence and incidence tracking.
• Lack of standardized diagnostic and treatment protocols leads to underdiagnosis and fragmented care.
• Inadequate rural healthcare infrastructure restricts access to neurological specialists.
• Limited budget allocation under NPCDCS for neurological disorders reduces capacity for focused interventions.
• Insufficient integration of mental health services despite high prevalence of neuropsychiatric symptoms.

Way Forward: Policy and Healthcare Priorities

• Establish a national Parkinson’s disease registry to generate reliable epidemiological data for evidence-based policymaking.
• Develop standardized clinical guidelines for diagnosis and management, incorporating motor and non-motor symptomatology.
• Increase budgetary allocation within NPCDCS specifically for neurological disorders, including PD.
• Expand neurological healthcare infrastructure in rural areas via telemedicine and mobile clinics.
• Integrate mental health services under the Mental Healthcare Act, 2017, into PD management protocols.
• Enhance public awareness campaigns through PDSI and government platforms to reduce stigma and promote early diagnosis.

Jharkhand & JPSC Relevance

• JPSC Paper: Paper 2 – Health and Social Welfare; Paper 3 – Economic Development
• Jharkhand Angle: Jharkhand’s rural population faces limited access to neurological care, mirroring national trends; lack of specialized PD services exacerbates disease burden.
• Mains Pointer: Frame answers highlighting rural healthcare gaps, constitutional rights under RPwD Act, and need for state-level neurological health initiatives.